EUVIMEDEUVIMED entdecken
Crossref

Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper

Marek Jutel iD, Ioana Agache iD, Magdalena Zemelka-Wiacek iD, Mübeccel Akdis iD, Tomás Chivato iD, Stefano Del Giacco iD, Pawel Gajdanowicz iD, Ibon Eguiluz Gracia iD, Ludger Klimek iD, Antti Lauerma iD, Markus Ollert iD, Liam O'Mahony iD und 28 weitere

Allergy · 2023-11 · 78 (11) · 2851-2874

DOI: 10.1111/all.15889 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, online erschienen am 10.10.2023. Verfasst von Marek Jutel und 39 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland. Hauptthemen laut MEDLINE: Hypersensitivity. Die Arbeit wurde bisher 312-mal zitiert (Crossref) und nennt 165 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The exponential growth of precision diagnostic tools, including omic technologies, molecular diagnostics, sophisticated genetic and epigenetic editing, imaging and nano‐technologies and patient access to extensive health care, has resulted in vast amounts of unbiased data enabling in‐depth disease characterization. New disease endotypes have been identified for various allergic diseases and triggered the gradual transition from a disease description focused on symptoms to identifying biomarkers and intricate pathogenetic and metabolic pathways. Consequently, the current disease taxonomy has to be revised for better categorization. This European Academy of Allergy and Clinical Immunology Position Paper responds to this challenge and provides a modern nomenclature for allergic diseases, which respects the earlier classifications back to the early 20th century. Hypersensitivity reactions originally described by Gell and Coombs have been extended into nine different types comprising antibody‐ (I‐III), cell‐mediated (IVa‐c), tissue‐driven mechanisms (V‐VI) and direct response to chemicals (VII). Types I‐III are linked to classical and newly described clinical conditions. Type IVa‐c are specified and detailed according to the current understanding of T1, T2 and T3 responses. Types V‐VI involve epithelial barrier defects and metabolic‐induced immune dysregulation, while direct cellular and inflammatory responses to chemicals are covered in type VII. It is notable that several combinations of mixed types may appear in the clinical setting. The clinical relevance of the current approach for allergy practice will be conferred in another article that will follow this year, aiming at showing the relevance in clinical practice where various endotypes can overlap and evolve over the lifetime.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypersensitivityHumansBiomarkers

Stichwörter der Autor:innen

EAACI position paperallergic diseaseshypersensitivitynomenclaturepathophysiology and mechanism

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland.
  • ALL-MED Medical Research Institute, Wroclaw, Poland.
  • Faculty of Medicine, Transylvania University, Brasov, Romania.
  • Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
  • School of Medicine, University CEU San Pablo, Madrid, Spain.
  • Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

ORCID-Profile: Marek Jutel, Ioana Agache, Magdalena Zemelka-Wiacek, Mübeccel Akdis, Tomás Chivato, Stefano Del Giacco, Pawel Gajdanowicz, Ibon Eguiluz Gracia, Ludger Klimek, Antti Lauerma, Markus Ollert, Liam O'Mahony, Jürgen Schwarze, Mohamed H Shamji, Isabel Skypala, Oscar Palomares, Oliver Pfaar, Maria Jose Torres, Jonathan A Bernstein, Alvaro A Cruz, Stephen R Durham, Stephen J Galli, R Maximiliano Gómez, Emma Guttman-Yassky, Tari Haahtela, Stephen T Holgate, Kenji Izuhara, Kenji Kabashima, Désirée E Larenas-Linnemann, Erica von Mutius, Kari C Nadeau, Ruby Pawankar, Tomas A E Platts-Mills, Scott H Sicherer, Hae-Sim Park, Stefan Vieths, Gary Wong, Luo Zhang, M Beatrice Bilò, Cezmi A Akdis

Zitieren

APA

Jutel, M., Agache, I., Zemelka-Wiacek, M., Akdis, M., Chivato, T., Del Giacco, S., Gajdanowicz, P., Gracia, I. E., Klimek, L., Lauerma, A., Ollert, M., O'Mahony, L., Schwarze, J., Shamji, M. H., Skypala, I., Palomares, O., Pfaar, O., Torres, M. J., Bernstein, J. A., …, & Akdis, C. A. (2023). Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper. Allergy, 78(11), 2851-2874. https://doi.org/10.1111/all.15889

Vancouver

Jutel M, Agache I, Zemelka-Wiacek M, Akdis M, Chivato T, Del Giacco S, et al. Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper. Allergy. 2023;78(11):2851-2874. doi:10.1111/all.15889

BibTeX
@article{Jutel2023,
  author = {Jutel, Marek and Agache, Ioana and Zemelka-Wiacek, Magdalena and Akdis, Mübeccel and Chivato, Tomás and Del Giacco, Stefano and Gajdanowicz, Pawel and Gracia, Ibon Eguiluz and Klimek, Ludger and Lauerma, Antti and Ollert, Markus and O'Mahony, Liam and Schwarze, Jürgen and Shamji, Mohamed H and Skypala, Isabel and Palomares, Oscar and Pfaar, Oliver and Torres, Maria Jose and Bernstein, Jonathan A and Cruz, Alvaro A and Durham, Stephen R and Galli, Stephen J and Gómez, R Maximiliano and Guttman-Yassky, Emma and Haahtela, Tari and Holgate, Stephen T and Izuhara, Kenji and Kabashima, Kenji and Larenas-Linnemann, Désirée E and von Mutius, Erica and Nadeau, Kari C and Pawankar, Ruby and Platts-Mills, Tomas A E and Sicherer, Scott H and Park, Hae-Sim and Vieths, Stefan and Wong, Gary and Zhang, Luo and Bilò, M Beatrice and Akdis, Cezmi A},
  title = {Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper},
  journal = {Allergy},
  year = {2023},
  volume = {78},
  number = {11},
  pages = {2851--2874},
  doi = {10.1111/all.15889}
}
Kostenlos starten →